PetVivo Holdings Inc Company Overview

PetVivo Holdings Inc logo
PetVivo Holdings Inc
Invesco QQQ Trust primary media

About PetVivo Holdings Inc

PetVivo (NASDAQ:PETV) is dedicated to improving the lives of animals through innovative healthcare solutions. The company's flagship product, Spryng, is a groundbreaking veterinary device designed to manage joint-related issues in pets, enhancing their quality of life. Spryng mimics the natural cartilage structure, providing effective joint support. PetVivo focuses on both research and development as well as manufacturing, aiming to bring more cutting-edge veterinary products to the market. Their mission is to deliver effective, high-quality treatments that enrich the lives of animals and their owners, while continuously exploring new applications and expanding their product lineup.

What is PetVivo Holdings Inc known for?

Snapshot

2009
Year founded
20
Employees
Minneapolis, USA
Head office
Loading Map...

Operations

All Locations
Minneapolis, US

Produtos e/ou serviços de PetVivo Holdings Inc

  • Spryng: An injectable veterinary device for arthritis treatment, providing cushioning and support for joints, enhancing mobility in animals.
  • Kush: A superior soft tissue supplement that acts similarly to cartilage, helping animals recover from injuries and surgeries.
  • TruGon: A preventative treatment to maintain joint health and delay the onset of arthritis in animals.
  • PetVivo Matrix: An advanced collagen matrix for promoting faster healing of wounds and injuries in pets.
  • Stem Cells: Innovation in stem cell therapy for regenerative treatment, focused on improving animal health and recovery rates.
  • VetGum: A specialized gum product delivering essential nutrients and supplements directly to animals for better overall health.

equipe executiva do PetVivo Holdings Inc

  • Mr. John LaiCEO, President & Director
  • Mr. Garry N. LowenthalChief Financial Officer
  • Mr. Michael Eldred BA, MBACommercialization & Operations Advisor and Executive Director
  • Mr. John F. DolanGeneral Counsel, Chief Business Development Officer & Secretary
  • Ms. April BoyceVice President of Sales & Marketing

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.